We are live on ! Find out more
SAM

Senzar Asset Management Portfolio holdings

AUM $34.7M
1-Year Est. Return 0.56%
This Fund
S&P 500
This Quarter Est. Return
-6.05%
1 Year Est. Return
+0.56%
3 Year Est. Return
-0.75%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$341M
AUM Growth
+$79.2M
Cap. Flow
+$101M
Cap. Flow %
29.66%
Top 10 Hldgs %
69.46%
Holding
33
New
7
Increased
16
Reduced
6
Closed
4

Top Buys

Rank Stock Value
1
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$25.8M
2
VTRS icon
Viatris
VTRS
+$25M
3
GSK icon
GSK
GSK
+$24.9M
4
ENTA icon
Enanta Pharmaceuticals
ENTA
+$12.4M
5
RPRX
Repros Therapeutics Inc.
RPRX
+$11.2M

Top Sells

Rank Stock Value
1
QCOR
QUESTCOR PHARMA INC
QCOR
+$14.6M
2
AMGN icon
Amgen
AMGN
+$14.1M
3
MDVN
MEDIVATION, INC.
MDVN
+$12.9M
4
CAH icon
Cardinal Health
CAH
+$6.56M
5
CYH icon
Community Health Systems
CYH
+$5.37M

Sector Composition

Rank Sector Weight
1 Healthcare 95.84%
2 Miscellaneous 4.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VTRS icon
1
Viatris
VTRS
$19.4B
$32.1M 9.41%
705,500
+514,800
+270% +$25M
GSK icon
2
GSK
GSK
$100B
$30.7M 9.01%
534,560
+405,680
+315% +$24.9M
TEVA icon
3
Teva Pharmaceuticals
TEVA
$42.4B
$30.6M 8.96%
568,396
+77,400
+16% +$4.1M
SNY icon
4
Sanofi
SNY
$106B
$27.5M 8.08%
488,100
+9,500
+2% +$510K
COV
5
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$25.2M 7.39%
+291,500
New +$25.8M
ABBV icon
6
AbbVie
ABBV
$453B
$24.9M 7.31%
431,400
+121,805
+39% +$6.76M
ENTA icon
7
Enanta Pharmaceuticals
ENTA
$410M
$22.4M 6.58%
566,903
+311,775
+122% +$12.4M
CYH icon
8
Community Health Systems
CYH
$408M
$17.2M 5.06%
380,787
-129,107
-25% -$5.37M
MDT icon
9
Medtronic
MDT
$120B
$14.8M 4.33%
238,100
+91,000
+62% +$5.79M
MGLN
10
DELISTED
Magellan Health Services, Inc.
MGLN
$11.4M 3.34%
208,300
+100,100
+93% +$5.74M
AGN
11
DELISTED
Allergan Inc
AGN
$10.2M 2.99%
57,300
+5,400
+10% +$897K
CNMD icon
12
CONMED
CNMD
$1.48B
$9.59M 2.81%
+260,400
New +$10.3M
OFIX icon
13
Orthofix Medical
OFIX
$378M
$9.34M 2.74%
301,598
-89,300
-23% -$2.96M
BIIB icon
14
Biogen
BIIB
$32.6B
$8.87M 2.6%
+26,800
New +$8.84M
INSM icon
15
Insmed
INSM
$27.6B
$8.66M 2.54%
663,300
-155,400
-19% -$2.34M
RPRX
16
DELISTED
Repros Therapeutics Inc.
RPRX
$7.46M 2.19%
+753,600
New +$11.2M
XNPT
17
DELISTED
XENOPORT, INC.
XNPT
$7.18M 2.11%
1,335,300
+162,600
+14% +$792K
RAD
18
DELISTED
Rite Aid Corporation
RAD
$5.97M 1.75%
+61,700
New +$7.97M
MNTA
19
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$5.16M 1.51%
454,600
+69,700
+18% +$795K
SGNT
20
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$4.82M 1.41%
154,900
-28,200
-15% -$764K
WCG
21
DELISTED
Wellcare Health Plans, Inc.
WCG
$4.57M 1.34%
75,700
-3,400
-4% -$225K
RIGL icon
22
Rigel Pharmaceuticals
RIGL
$909M
$4.03M 1.18%
207,440
+115,120
+125% +$3.25M
FPRX
23
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$3.5M 1.03%
298,300
+36,300
+14% +$458K
CORI
24
DELISTED
Corium International, Inc.
CORI
$3.43M 1.01%
558,820
+47,320
+9% +$315K
CNCE
25
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$3.29M 0.97%
+261,200
New +$2.53M
1
2

Similar funds

BCP
Blum Capital Partners San Francisco, California $34.1M AUM 1.14% 1-Year Est. Return
PRHC
P.R. Herzig & Co Roslyn Heights, New York $45.9M AUM 15.88% 1-Year Est. Return
NAM
Needelman Asset Management Ladera Ranch, California $46M AUM 8.27% 1-Year Est. Return
GG
Gores Group Beverly Hills, California $22.3M AUM 4.58% 1-Year Est. Return
SM
SLS Management New York $17.2M AUM 14.82% 1-Year Est. Return
BC
Breogan Capital New York $56.4M AUM
SCPM
Social Capital PEP Management Palo Alto, California $56.5M AUM
FAM
Fortaleza Asset Management Chicago, Illinois $12.3M AUM 48.33% 1-Year Est. Return

Senzar Asset Management's Q3 2014 Portfolio in Review

As of Q3 2014, Senzar Asset Management held 33 positions worth $341M, up 30% from $262M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Senzar Asset Management deployed $101M of net new capital in Q3 2014, opening 7 new positions and adding to 16 existing holdings. Its largest new stake was COVIDIEN PLC COM SHS NEW (IRELAND): 291,500 shares worth $25.2M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 84% a quarter earlier, followed by Miscellaneous.

On the sell side, the largest reduction was Community Health Systems, an estimated $5.37M trimmed.

  • Senzar Asset Management's largest Q3 2014 buy was COVIDIEN PLC COM SHS NEW (IRELAND): 291,500 shares worth $25.2M.
  • Senzar Asset Management added most to Viatris in Q3 2014, an estimated $25M increase.
  • Senzar Asset Management's biggest Q3 2014 reduction was Community Health Systems, cutting an estimated $5.37M.
  • Senzar Asset Management fully exited QUESTCOR PHARMA INC in Q3 2014, selling an estimated $14.6M.
  • Senzar Asset Management's ten largest holdings make up 69% of its $341M portfolio in Q3 2014.
  • Senzar Asset Management opened 7 new positions and closed 4 in Q3 2014.
  • Senzar Asset Management's portfolio value rose 30% quarter-over-quarter to $341M.

Based on Senzar Asset Management's 13F filing for Q3 2014, filed 14 Nov 2014.